5-Oxa-13,14-didehydro-PGE.sub.1 compounds
    86.
    发明授权
    5-Oxa-13,14-didehydro-PGE.sub.1 compounds 失效
    5-Oxa-13,14-二脱氢PGE {HD 1 {B化合物

    公开(公告)号:US4119664A

    公开(公告)日:1978-10-10

    申请号:US775074

    申请日:1977-03-07

    申请人: Herman W. Smith

    发明人: Herman W. Smith

    摘要: This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.

    摘要翻译: 本发明包括其中C-13和C-14之间的双键被三键取代的前列腺素的某些类似物。 本发明还提供了可用于制备上述前列腺素类似物的新颖化学方法和新型化学中间体。 这些前列腺素类似物表现出前列腺素样活性,因此可用于与前列腺素相同的药理学目的。 其中包括降血压,术中诱导,生殖周期调节,胃分泌作用等。

    CIS-4,5-Didehydro-13,14-didehydro-PGF.sub.1 compounds
    87.
    发明授权
    CIS-4,5-Didehydro-13,14-didehydro-PGF.sub.1 compounds 失效
    CIS-4,5-Didehydro-13,14-二脱氢-PGF {HD 1 {B化合物

    公开(公告)号:US4119662A

    公开(公告)日:1978-10-10

    申请号:US776553

    申请日:1977-03-07

    申请人: Herman W. Smith

    发明人: Herman W. Smith

    摘要: This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.The present application is a divisional application of Ser. No. 657,739, filed Feb. 13, 1976, now issued as U.S. Pat. No. 4,029,681 on June 14, 1977.

    摘要翻译: 本发明包括其中C-13和C-14之间的双键被三键取代的前列腺素的某些类似物。 本发明还提供了可用于制备上述前列腺素类似物的新颖化学方法和新型化学中间体。 这些前列腺素类似物表现出前列腺素样活性,因此可用于与前列腺素相同的药理学目的。 其中包括降血压,术中诱导,生殖周期调节,胃分泌作用等。

    5-Oxa-13,14-didehydro-PGF.sub.1 compounds
    88.
    发明授权
    5-Oxa-13,14-didehydro-PGF.sub.1 compounds 失效
    5-Oxa-13,14-二脱氢-PGF {HD 1 {B化合物

    公开(公告)号:US4118416A

    公开(公告)日:1978-10-03

    申请号:US776554

    申请日:1977-03-07

    申请人: Herman W. Smith

    发明人: Herman W. Smith

    摘要: This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.

    摘要翻译: 本发明包括其中C-13和C-14之间的双键被三键取代的前列腺素的某些类似物。 本发明还提供了可用于制备上述前列腺素类似物的新颖化学方法和新型化学中间体。 这些前列腺素类似物表现出前列腺素样活性,因此可用于与前列腺素相同的药理学目的。 其中包括降血压,术中诱导,生殖周期调节,胃分泌作用等。